Patents by Inventor Jonathan Leitersdorf

Jonathan Leitersdorf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220012767
    Abstract: The real-time digital asset sampling apparatuses, methods and systems (“RDA”) transform ad bidding requests via RDA components and/or the like into ad pricing indices, financial instruments and/or the like. In one implementation, the RDA may determine a digital asset market bid sampling distribution for a digital asset associated with a plurality of attribute parameters; submit a digital asset pricing bid to an exchange platform; determine a current digital asset price based on bidding result of the digital asset market bids sampling; and aggregate the determined current digital asset price to generate a digital asset price index for the digital asset associated with a plurality of attribute parameters.
    Type: Application
    Filed: July 14, 2021
    Publication date: January 13, 2022
    Inventors: Jonathan LEITERSDORF, Milosz TANSKI
  • Patent number: 11068925
    Abstract: The real-time digital asset sampling apparatuses, methods and systems (“RDA”) transform ad bidding requests via RDA components and/or the like into ad pricing indices, financial instruments and/or the like. In one implementation, the RDA may determine a digital asset market bid sampling distribution for a digital asset associated with a plurality of attribute parameters; submit a digital asset pricing bid to an exchange platform; determine a current digital asset price based on bidding result of the digital asset market bids sampling; and aggregate the determined current digital asset price to generate a digital asset price index for the digital asset associated with a plurality of attribute parameters.
    Type: Grant
    Filed: January 13, 2014
    Date of Patent: July 20, 2021
    Assignee: ADFIN SOLUTIONS, INC.
    Inventors: Jonathan Leitersdorf, Milosz Tanski
  • Publication number: 20150363820
    Abstract: The real-time digital asset sampling apparatuses, methods and systems (“RDA”) transform ad bidding requests via RDA components and/or the like into ad pricing indices, financial instruments and/or the like. In one implementation, the RDA may determine a digital asset market bid sampling distribution for a digital asset associated with a plurality of attribute parameters; submit a digital asset pricing bid to an exchange platform; determine a current digital asset price based on bidding result of the digital asset market bids sampling; and aggregate the determined current digital asset price to generate a digital asset price index for the digital asset associated with a plurality of attribute parameters.
    Type: Application
    Filed: January 13, 2014
    Publication date: December 17, 2015
    Applicant: ADFIN SOLUTIONS
    Inventors: Jonathan LEITERSDORF, Milosz TANSKI
  • Patent number: 7354991
    Abstract: Short peptides are provided, which bind to a body fluid sample obtained from a schizophrenic patient at a substantively higher level than to a body fluid sample obtained from a non-schizophrenic individual. The peptides are no more than 10 amino acids long and comprise a continuous sequence of at least 5 amino acids which consists of at least one positively charged amino acid at one of its ends. The provided peptides, which are the putative binding sites of autoantibodies found in high levels in schizophrenic individuals, are thus useful in diagnosis of schizophrenia.
    Type: Grant
    Filed: March 21, 2002
    Date of Patent: April 8, 2008
    Assignee: Yeda Research and Development Co. Ltd
    Inventors: Jonathan Leitersdorf, legal representative, Michael Deckmann
  • Publication number: 20050089927
    Abstract: Short peptides are provided, which bind to a body fluid sample obtained from a schizophrenic patient at a substantively higher level than to a body fluid sample obtained from a non-schizophrenic individual. The peptides are no more than 10 amino acids long and comprise a continuous sequence of at least 5 amino acids which consists of at least one positively charged amino acid at one of its ends. The provided peptides, which are the putative binding sites of autoantibodies found in high levels in schizophrenic individuals, are thus useful in diagnosis of schizophrenia.
    Type: Application
    Filed: March 21, 2002
    Publication date: April 28, 2005
    Inventors: Michael Deckmann, Jonathan Leitersdorf